Bronchitis Treatment Market by Indication (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Class of Drugs, End User - Global Forecast 2023-2030

Bronchitis Treatment Market by Indication (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Class of Drugs, End User - Global Forecast 2023-2030


The Bronchitis Treatment Market is projected to reach USD 10.62 billion by 2030 from USD 6.30 billion in 2022, at a CAGR of 6.73% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Bronchitis Treatment Market.
  • Based on Indication, market is studied across Acute Bronchitis and Chronic Bronchitis. The Chronic Bronchitis is projected to witness significant market share during forecast period.
  • Based on Treatment, market is studied across Drugs and Oxygen Therapy. The Oxygen Therapy is projected to witness significant market share during forecast period.
  • Based on Class of Drugs, market is studied across Anti-inflammatory Drugs, Antibiotics, and Bronchodilator. The Bronchodilator is projected to witness significant market share during forecast period.
  • Based on End User, market is studied across Clinics, Hospital Pharmacies, and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Bronchitis Treatment Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Bronchitis Treatment Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Bronchitis Treatment Market, highlighting leading vendors and their innovative profiles. These include American Well Corporation, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Cigna Corporation, Cipla Limited, Dr. Reddy’s Laboratories Ltd, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Services, Inc, Lupin Limited, Melinta Therapeutics, Inc., Merck and Co. Inc., Novartis International AG, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi S.A, Sun Pharmaceutical Industries Ltd., TelaCare Health Solutions, LLC, Teva Pharmaceutical Industries Ltd., and Viatris Inc..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Bronchitis Treatment Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Bronchitis Treatment Market?
  3. What is the competitive strategic window for identifying opportunities in the Bronchitis Treatment Market?
  4. What are the latest technology trends and regulatory frameworks in the Bronchitis Treatment Market?
  5. What is the market share of the leading vendors in the Bronchitis Treatment Market?
  6. Which modes and strategic moves are suitable for entering the Bronchitis Treatment Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Bronchitis Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic obstructive pulmonary disease (COPD) patients
5.1.1.2. Growing healthcare expenditure by governments and private organizations
5.1.1.3. Increasing initiatives by government and healthcare organizations to create awareness about bronchitis
5.1.2. Restraints
5.1.2.1. Availability of alternatives and high cost of products
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities for improving respiratory therapies for bronchitis treatment
5.1.3.2. Increasing preference for personalized medicines for bronchitis treatment
5.1.4. Challenges
5.1.4.1. Time consuming and stringent regulatory environment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Bronchitis Treatment Market, by Indication
6.1. Introduction
6.2. Acute Bronchitis
6.3. Chronic Bronchitis
7. Bronchitis Treatment Market, by Treatment
7.1. Introduction
7.2. Drugs
7.3. Oxygen Therapy
8. Bronchitis Treatment Market, by Class of Drugs
8.1. Introduction
8.2. Anti-inflammatory Drugs
8.3. Antibiotics
8.4. Bronchodilator
9. Bronchitis Treatment Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Hospital Pharmacies
9.4. Retail Pharmacies
10. Americas Bronchitis Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Bronchitis Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Bronchitis Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. American Well Corporation
14.1.2. AstraZeneca PLC
14.1.3. Boehringer Ingelheim International GmbH
14.1.4. Cadila Pharmaceuticals Limited
14.1.5. Cigna Corporation
14.1.6. Cipla Limited
14.1.7. Dr. Reddy’s Laboratories Ltd
14.1.8. F. Hoffmann-La Roche Ltd.
14.1.9. GlaxoSmithKline Pharmaceuticals Limited
14.1.10. Johnson & Johnson Services, Inc
14.1.11. Lupin Limited
14.1.12. Melinta Therapeutics, Inc.
14.1.13. Merck and Co. Inc.
14.1.14. Novartis International AG
14.1.15. Pfizer Inc.
14.1.16. Reckitt Benckiser Group PLC
14.1.17. Sanofi S.A
14.1.18. Sun Pharmaceutical Industries Ltd.
14.1.19. TelaCare Health Solutions, LLC
14.1.20. Teva Pharmaceutical Industries Ltd.
14.1.21. Viatris Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings